Actually, we have Veenu Aulakh to thank for putting the DiabetesMine Design Challenge on the map. She heard me give a keynote speech at the Robert Wood Johnson Foundation’s Project HealthDesign event a few years ago, calling for more patient involved in medical device design, and it seems that a light bulb went on: the California HealthCare Foundation strives to foster better tools for patient self-management of chronic illnesses, so why not support a Crowdsourcing…Read more »
Richard Vaughn is a bit of a legend in the diabetes online community. Known more widely as Richard157 on several diabetes forums, Richard began sharing his story of living with type 1 diabetes for over 60 years via forum posts in 2007 and has become an inspiration for many. Last week, Richard also became a self-published author, releasing his memoirs, Beating The Odds: 64 Years of Diabetes Health, on Amazon.com.
Born in 1939 in rural…
When the JDRF recently announced its newest artificial pancreas push — a partnership with Animas and Dexcom to actually develop a commercial product — head of the project Aaron Kowalski kindly agreed to answer reader questions here.
Today, I bring you those answers, direct “from the horses’ mouth,” as it were.
Q) How much more advanced will this be than the Medtronic Paradigm Veo system launched in Europe, which stops insulin delivery for…
Today, just a sampling of some of the interesting stuff presented at last week’s Diabetes Technology Society meeting, that will be out on the market in … um… some years from now (?):
IN-105 Oral Insulin for Type 2 diabetes – Biocon Limited, apparently India’s premier biotechnology company, has been developing oral insulin tablets for some years now. Positive research results were announced last year. And they’re not just for basal use, either. Studies confirmed…Read more »
The Diabetes Technology Society held its annual meeting last Thursday through Saturday, which always takes place just about a mile and a half from my house. But guess what? This was the very first year that I found myself on the inside of this exclusive event, participating in a panel (the very last panel of the 3-day event) on “technologies to drive patient adherence.”
The term “adherence” made me bristle, too, because it sounds like…